LINC-ROR and ovarian cancer: In this regard, a former study has examined the expression of LINC-ROR in various cell lines and human tumor tissue samples and reported that the expression of LINC-ROR increases in cervical, esophageal, and ovarian cancers, but decreases in breast, colon, sarcoma and melanoma cancers.